IQVIA announced a strategic long-term partnership with Boehringer Ingelheim focused on commercial data transformation.[1][2] Boehringer Ingelheim selected IQVIA's Data-as-a-Service (DaaS+) technology to harmonize and transform its global commercial data.[1][2] The collaboration will enable Boehringer Ingelheim to expand its commercial data products and analytics ambitions across therapeutic areas and regional teams.[1][2] The partnership supports upcoming product launches and enhances existing market performance in 59 countries.[1][2] It will provide harmonized data for all market, brand and franchise reports, including global product mastering and effective data management.[1][2] IQVIA has approximately 91,000 employees in more than 100 countries and provides clinical research services, business insights and health intelligence.[1][2] Boehringer Ingelheim is a biopharmaceutical company with approximately 54,500 employees operating in more than 130 markets.[2]